55 results
Keyword Neupro - Cerotti Remove keyword
-
List item
Committee for Medicinal Products for Human Use (CHMP): 9-12 October 2017
European Medicines Agency, London, UK, from 09/10/2017 to 12/10/2017, Last updated: 06/01/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 1-4 December 2014
European Medicines Agency, London, UK, from 01/12/2014 to 04/12/2014, Last updated: 13/08/2013 -
List item
Press release: European Medicines Agency: Committee for Medicinal Products for Human Use 11-14 December 2005
CHMP, Last updated: 15/12/2005authorisation applications for Neupro (rotigotine), Schwarz Pharma … rotigotine), Schwarz Pharma Ltd. Neupro is indicated for the treatment … -
List item
Sampling and testing
Last updated: 28/03/2019 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 April 2011
European Medicines Agency, London, UK, from 11/04/2011 to 14/04/2011, Last updated: 11/06/2010the authorised medicine Neupro. Positive opinion for generic … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,13-16 November 2006
CHMP, Last updated: 17/11/2006patients with epilepsy. Neupro (rotigotine), from Schwarz … combination with levodopa. Neupro was first granted a marketing … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 June 2015
European Medicines Agency, London, UK, from 08/06/2015 to 11/06/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 September 2014
European Medicines Agency, London, UK, from 08/09/2014 to 11/09/2014, Last updated: 13/08/2013 -
List item
Committee for Medicinal Products for Human Use (CHMP): 7-10 November 2016
European Medicines Agency, London, UK, from 07/11/2016 to 10/11/2016, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 6-9 November 2017
European Medicines Agency, London, UK, from 06/11/2017 to 09/11/2017, Last updated: 06/01/2014 -
List item
PRAC: meeting archive 2012-2014
Last updated: 13/05/2016 -
List item
Clinical investigation of medicinal products in the treatment of Parkinson's disease - Scientific guideline
Last updated: 06/07/2012 -
List item
PRAC: Committee agendas, minutes and meeting highlights report archive 2012-2013
Last updated: 01/01/2015 -
List item
Management Board meeting: 1 October 2009
European Medicines Agency, London, UK, 01/10/2009, Last updated: 01/09/2011 -
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 January 2018
European Medicines Agency, London, UK, from 22/01/2018 to 25/01/2018, Last updated: 06/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 7-10 December 2020
Virtual meeting, from 07/12/2020 to 10/12/2020, Last updated: 04/11/2019 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 September 2010
European Medicines Agency, London, UK, from 20/09/2010 to 23/09/2010, Last updated: 16/02/2010 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 February 2021
PRAC, Last updated: 12/02/2021 -
List item
Key documents
Last updated: 21/12/2020 -
List item
CHMP: meeting archive 2001-2009
Last updated: 18/11/2013 -
List item
News: European Medicines Agency takes a further step in its interaction with patients and consumers
Last updated: 12/12/2009 -
List item
Public data from Article 57 database
Last updated: 17/10/2022 -
List item
CHMP: meeting archive 2010-2012
Last updated: 17/12/2013 -
List item
CHMP: meeting archive 2016-2018
Last updated: 26/02/2020 -
List item
News: European Medicines Agency bids farewell to CHMP Pharmacovigilance Working Party
CHMP, Last updated: 26/07/2012